4//SEC Filing
Cavanaugh Michael R. 4
Accession 0001493152-19-001090
CIK 0001438943other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:05 PM ET
Size
7.5 KB
Accession
0001493152-19-001090
Insider Transaction Report
Form 4
Cavanaugh Michael R.
DirectorChief Executive Officer
Transactions
- Other
Common Stock
2019-01-25+572,291→ 879,791 total - Other
Common Stock Warrants (right to buy)
2019-01-25−50,000→ 0 totalExercise: $3.00From: 2018-10-22Exp: 2023-10-22→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Pursuant to that certain Amendment to Securities Purchase Agreement dated January 18, 2019 (the "Amendment") to a Securities Purchase Agreement dated October 19, 2018 (the "SPA"), the Reporting Person was issued additional shares of the Issuer's common stock for no additional consideration effective upon receipt by the Issuer of warrants issued to the Reporting Person pursuant to the SPA (the "Warrants").
- [F2]Pursuant to the Amendment, the Warrants were cancelled.
Documents
Issuer
Vitality Biopharma, Inc.
CIK 0001438943
Entity typeother
Related Parties
1- filerCIK 0001757622
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:05 PM ET
- Size
- 7.5 KB